University, Montpellier
Montpellier, France
Location status: Recruiting
Location contact
Didier BESSIS
CONTACT
NCT Number: NCT06073171
It's a study on Syndromic or Isolated Cutis Tricolor and had as main goal to identify the associated gene to the disease thanks to genetic analysis on minors patients and their parents reach by cutis Tricolor or not.
Interested in participating?
Request Info4 year–60 year
All sexes
Interventional
Not applicable
Montpellier, France
Location status: Recruiting
Didier BESSIS
CONTACT
Cutis Tricolor (CT) is a rare cutaneous anomaly defined by pigmentary disorders associating large hyper- and hypopigmented macules of immediate proximity, selectively affecting the trunk. CT can be isolated, sporadic or integrated as a complex syndromic form such as Ruggieri-Happle syndrome (RHS) or various forms of pigmentovascular phacomatosis. A recent analysis of one case of RHS followed by CHU of Montpellier by whole exome sequencing allows the identification of a frameshift pathogen variant (heterozygous state) of a candidate gene.
The main objective is to confirm the association of the candidate gene with syndromic CT (SCT, Ruggierri-Happle syndrome) and non syndromic CT, from a genetic molecular blood and biopsy analysis of patients reach by CT and their parents presenting the disease or not. Furthermore, other objectives are to identify others associated candidates genes and to know better cutaneous pigmentary troubles factors, neurologics and eye abnormalities by identifying the differents cellulars pathways particularly the inflammatory pathway in the pathology of SCT.
First of all, it will have a pre-inclusion visit where Dr WILLEMS. M (Clinical Genetic Department - CHU Montpellier, France) and Pr BESSIS. D (Dermatology Department - CHU Montpellier, France) will explain the study's progress. Then, during the inclusion visit, families will sign inform consent for inclusion in the study. The same day, datas will be collected on demographic, clinical datas, including (i) a description of cutaneous, morphologic and extra-cutaneous anomalies and (ii) a cutaneous biopsy and (iii) a blood test will be done.
The genetics exams results will be return to patients during an usual follow-up visit, 12 months after their inclusion in the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
7.5 mL will be sampled on EDTA tube for each patient
4 mm of damaged skin will be sampled after a premedication with lidocaine gel for 4 patients
Sequencing on Illumina NovaSeq6000 platform, using the Twist Bioscience Human Core Exome kit + IntegraGen content, average 37Mb. This sequencing will be realised by external provider, IntegraGen society.
Time frame: 12 months
Time frame: 12 months
Contact information is provided by the study sponsor or research team.
Didier BESSIS, Prof.
CONTACT
Marjolaine WILLEMS, Dr
CONTACT
University Hospital, Montpellier
Other
Acronym: Cutis Tricolor
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01631617
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Bethesda, Maryland, United States
View Trial DetailsNCT05561595
Body Weight, Cancer
Gainesville, Florida, United States
View Trial DetailsNCT07049575
Bacterial Infections, Bacterial Infections and Mycoses
Phoenix, Arizona, United States
View Trial DetailsNCT07717346
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Miami, Florida, United States
View Trial Details